Anti-BRAF antibody [EP152Y]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
4
(12 Reviews)
|
(37 Publications)
Anti-BRAF antibody [EP152Y] (ab33899) is a rabbit monoclonal antibody detecting BRAF in Western Blot, IP, IHC-P. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 30 publications
- Trusted since 2006
View Alternative Names
BRAF1, RAFB1, BRAF, Serine/threonine-protein kinase B-raf, Proto-oncogene B-Raf, p94, v-Raf murine sarcoma viral oncogene homolog B1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BRAF antibody [EP152Y] (AB33899)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human breast cancer tissue sections labeling BRAF with purified ab33899 at 1/100 dilution (4.77 μg/ml). Heat mediated antigen retrieval was performed using heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BRAF antibody [EP152Y] (AB33899)
This image shows paraffin embedded human prostate cancer tissue sample stained with ab33899 (unpurified) at 1/250 dilution.
- IP
Unknown
Immunoprecipitation - Anti-BRAF antibody [EP152Y] (AB33899)
ab33899 (Purified) at 1/20 dilution (20 μg/ml) immunoprecipitating BRAF in HeLa whole cell lysate.
Lane 1 (input) : HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate 10 μg
Lane 2 (+) : ab33899 & HeLa whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab33899 in HeLa whole cell lysate
For western blotting, ab33899 at 1/500 and VeriBlot for IP secondary antibody (HRP) (ab131366) was used as the secondary antibody at 1/1000 dilution.
Blocking and diluting buffer : 5% NFDM /TBST .
All lanes:
Immunoprecipitation - Anti-BRAF antibody [EP152Y] (ab33899)
Predicted band size: 84 kDa
false
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BRAF antibody [EP152Y] (AB33899)
ab33899 (unpurified) staining B Raf cells from human prostate tissue by immunohistochemistry (formalin/PFA-fixed paraffin-embedded sections). Cells were formaldehyde fixed and permeabilized in PBS-Tween 20 prior to blocking in 70% serum for 10 minutes at 25°C. The primary antibody was diluted 1/250 and incubated with the sample for 1 hour at 25°C. A biotin conjugated goat polyclonal to mouse Ig was used as the secondary.
- WB
Lab
Western blot - Anti-BRAF antibody [EP152Y] (AB33899)
Lanes 1 - 3 : Merged signal (red and green). Green - ab33899 (unpurified) observed at 90 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab33899 was shown to recognize B Raf in wild-type HAP1 cells as signal was lost at the expected MW in B Raf knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and B Raf knockout samples were subjected to SDS-PAGE. ab33899 and ab8245 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-BRAF antibody [EP152Y] (ab33899) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 40 µg
Lane 2:
BRAF knockout HAP1 whole cell lysate at 40 µg
Lane 3:
HeLa whole cell lysate at 40 µg
Predicted band size: 84 kDa
false
- WB
Lab
Western blot - Anti-BRAF antibody [EP152Y] (AB33899)
Lanes 1- 2 : Merged signal (red and green). Green - ab33899 observed at 90 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab33899 was shown to react with BRAF in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265373 (knockout cell lysate ab257078) was used. Wild-type HeLa and BRAF knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab33899 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-BRAF antibody [EP152Y] (ab33899) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
BRAF knockout HeLa cell lysate at 20 µg
Predicted band size: 84 kDa
Observed band size: 90 kDa
false
- WB
Supplier Data
Western blot - Anti-BRAF antibody [EP152Y] (AB33899)
Blocking and diluting buffer and concentration : 5% NFDM/TBST The bands below 90 kDa in lane 1 may be caused by degradation. Lysates were freshly made and used immediately to minimize protein degradation. In Western blot, anti- Vinculin antibody (ab129002) loading control staining at 1/10000 dilution. Anti-BRAF antibody (ab33899) total protein control staining at 1/1000 dilution. Exposure time : 3 minutes
All lanes:
Western blot - Anti-BRAF (phospho S446) antibody [EPR28069-63] (<a href='/en-us/products/primary-antibodies/braf-phospho-s446-antibody-epr28069-63-ab313793'>ab313793</a>) at 1/1000 dilution
Lane 1:
Wild-type HAP1(human chronic myelogenous leukemia near-haploid cell line) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
BRAF knockout HAP1 whole cell lysate (untreated membrane) at 20 µg
Lane 3:
Wild-type HAP1 whole cell lysate (phosphatase treated membrane) at 20 µg
Lane 4:
BRAF knockout HAP1 whole cell lysate (phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 90 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-BRAF antibody [EP152Y] (AB33899)
All lanes:
Western blot - Anti-BRAF antibody [EP152Y] (ab33899) at 1/2000 dilution
Lane 1:
HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 15 µg
Lane 2:
Mouse brain lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 84 kDa
Observed band size: 87 kDa
false
- WB
Unknown
Western blot - Anti-BRAF antibody [EP152Y] (AB33899)
All lanes:
Western blot - Anti-BRAF antibody [EP152Y] (ab33899) at 1/1000 dilution
Lane 1:
Lysate prepared from mouse brain
Lane 2:
Lysate prepared from mouse heart
Lane 3:
Lysate prepared from mouse kidney
Lane 4:
Lysate prepared from mouse spleen
Lane 5:
Lysate prepared from rat brain
Lane 6:
Lysate prepared from rat heart
Lane 7:
Lysate prepared from rat kidney
Lane 8:
Lysate prepared from rat spleen
Predicted band size: 84 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-BRAF antibody [EP152Y] (AB33899)
Blocking and diluting buffer and concentration : 5% NFDM/TBST The band below 90 kDa in lane 1 may be caused by degradation. Lysates were freshly made and used immediately to minimize protein degradation. In Western blot, anti-GAPDH antibody (ab181602) loading control staining at 1/200000 dilution. Anti-BRAF antibody (ab33899) total protein control staining at 1/1000 dilution. Exposure time : Lane 1, 2 : 3 minutes; Lane 3, 4 : 15 seconds
All lanes:
Western blot - Anti-BRAF (phospho S446) antibody [EPR28069-63] (<a href='/en-us/products/primary-antibodies/braf-phospho-s446-antibody-epr28069-63-ab313793'>ab313793</a>) at 1/1000 dilution
Lane 1:
NIH/3T3 (mouse embryonic fibroblast) whole cell lysate (untreated membrane) at 20 µg
Lane 2:
NIH/3T3 whole cell lysate (phosphatase treated membrane) at 20 µg
Lane 3:
PC-12 (rat adrenal gland pheochromocytoma) whole cell lysate (untreated membrane) at 20 µg
Lane 4:
PC-12 whole cell lysate (phosphatase treated membrane) at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 90 kDa
false
- WB
Lab
Western blot - Anti-BRAF antibody [EP152Y] (AB33899)
All lanes:
Western blot - Anti-BRAF antibody [EP152Y] (ab33899) at 1/5000 dilution
All lanes:
PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysates at 15 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 84 kDa
Observed band size: 87 kDa
false
- WB
Unknown
Western blot - Anti-BRAF antibody [EP152Y] (AB33899)
All lanes:
Western blot - Anti-BRAF antibody [EP152Y] (ab33899) at 1/5000 dilution
All lanes:
HeLa cell lysate
Predicted band size: 84 kDa
Observed band size: 87 kDa
false
- WB
CiteAb
Western blot - Anti-BRAF antibody [EP152Y] (AB33899)
BRAF western blot using anti-BRAF antibody [EP152Y] ab33899. Publication image and figure legend from Zhang, H., Zheng, D., et al., 2016, Sci Rep, PubMed 27767059.
ab33899 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab33899 please see the product overview.
Compounds 1, 2, and 9 downregulate RAF-MAPK signaling pathway and snail protein level.RAS-RAF-MEK-ERK cascades and snail protein were analyzed by western blot. TE1 cells were treated with 1, 2, or 9 with various concentrations (0, 10, 20 μM) for 48 h. Sorafenib (SFB) was used as the positive control.
false
Related conjugates and formulations (3)
-
Anti-BRAF antibody [EP152Y] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-BRAF antibody [EP152Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-BRAF antibody [EP152Y]
Reactivity data
Product details
What is this antibody validated in?
Anti-BRAF antibody [EP152Y] (ab33899) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P) in Human, Mouse, Rat samples.
What is the molecular weight of BRAF?
Anti-BRAF [EP152Y] (ab33899) specifically detects a band for BRAF (UniProt: P15056) at a molecular weight of 85kDa.
Trusted by the scientific community
Anti-BRAF [EP152Y] (ab33899) was first used in a scientific publication in 2006 and has been cited over 30 times in peer-reviewed journals.
Reviewed by scientists
Anti-BRAF [EP152Y] (ab33899) has over 10 independent reviews from customers.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-BRAF antibody [EP152Y] (ab33899) has been confirmed by Western blot testing in BRAF Knockout HAP1 cells.
Other related products
We have a range of other formats of antibody clone [EP152Y] also available for your convenience: ab33899, Carrier free - ab189351, Alexa Fluor® 647 - ab309081, Alexa Fluor® 488 - ab309244
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (37)
Recent publications for all applications. Explore the full list and refine your search
Journal of nanobiotechnology 23:129 PubMed39979881
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC molecular and cell biology 26:6 PubMed39838328
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed39684934
2024
Applications
Unspecified application
Species
Unspecified reactive species
EMBO molecular medicine 16:1755-1790 PubMed39030302
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer gene therapy 30:1414-1425 PubMed37558749
2023
Applications
Unspecified application
Species
Unspecified reactive species
Signal transduction and targeted therapy 8:96 PubMed36872366
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of oncology 61: PubMed36263632
2022
Applications
Unspecified application
Species
Unspecified reactive species
Osteoarthritis and cartilage 30:1443-1454 PubMed36100125
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 13:701 PubMed35961969
2022
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 22:298 PubMed35313850
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com